Virtus ETF Advisers LLC Atai Life Sciences N.V. Transaction History

Virtus ETF Advisers LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$1.27 - $2.28 $7,029 - $12,619	-5,535 Reduced 9.06%	55,554 $71,000
Q2 2023 Aug 14, 2023	BUY	$1.44 - $2.19 $40,968 - $62,305	28,450 Added 87.17%	61,089 $105,000
Q1 2023 May 15, 2023	SELL	$1.17 - $2.7 $14,677 - $33,871	-12,545 Reduced 27.76%	32,639 $59,000
Q4 2022 Feb 14, 2023	BUY	$2.38 - $3.55 $30,566 - $45,592	12,843 Added 39.71%	45,184 $120,000
Q3 2022 Nov 14, 2022	BUY	$3.14 - $4.87 $737 - $1,144	235 Added 0.73%	32,341 $107,000
Q2 2022 Aug 12, 2022	BUY	$3.03 - $5.32 $50,410 - $88,508	16,637 Added 107.55%	32,106 $117,000
Q1 2022 May 16, 2022	SELL	$4.66 - $7.66 $4,305 - $7,077	-924 Reduced 5.64%	15,469 $79,000
Q4 2021 Feb 14, 2022	BUY	$6.82 - $17.8 $111,800 - $291,795	16,393 New	16,393 $125,000

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.